Laekna, Inc. announced the interim results for the six months ended June 30, 2023, and provided the latest updates on the clinical and preclinical development of its drug candidates.
Laekna, Inc. announced the interim results for the six months ended June 30, 2023, and provided the latest updates on the clinical and preclinical development of its drug candidates.